Mogrify extends Series A financing to $46 million USD

FHS
October 2, 2023
10:56 am

Mogrify Limited (Mogrify®), a biopharmaceutical company transforming the lives of patients through a novel class of in vivo reprogramming therapies, announced today an additional $10 million USD closing of its Series A financing.

Kaiser Deploys Abridge’s GenAI Clinical Documentation Across Enterprise

What You Should Know: – Kaiser Permanente, the nation’s largest non-profit integrated healthcare provider, has announced the rollout of a new assisted clinical documentation tool

August 15, 2024

Mydecine Announces Conditional Approval of CSE Listing | Psychedelic Invest

Mydecine Innovations Group Inc. (NEO:MYCO) (OTC: MYCOF) (FSE: 0NFA) (“Mydecine” or the “Company”), is pleased to announce that it has made an application and received

August 31, 2023

3M FY 23/24: BRAIN Biotech looks optimistic to stay on the growth path for fiscal year 2023/24 – Biotech Investments

EQS-News: BRAIN Biotech AG / Key word(s): Quarterly / Interim Statement 3M FY 23/24: BRAIN Biotech looks optimistic to stay on the growth path for

February 29, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.